US 8946300
Use of rasagilline for the treatment of restless legs syndrome
granted A61KA61K2300/00A61K31/135
Quick answer
US patent 8946300 (Use of rasagilline for the treatment of restless legs syndrome) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K2300/00, A61K31/135, A61K31/16, A61K31/428